These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 7825978

  • 1. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry.
    Sebille S, Morjani H, Poullain MG, Manfait M.
    Anticancer Res; 1994; 14(6A):2389-93. PubMed ID: 7825978
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacological properties of S9788, a new modulator of multidrug resistance].
    Bull Cancer; 1994 Feb; 81(2):93-103. PubMed ID: 7894124
    [Abstract] [Full Text] [Related]

  • 3. Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin.
    Pérez V, Pierré A, Léonce S, Anstett M, Atassi G.
    Anticancer Res; 1993 Feb; 13(4):985-90. PubMed ID: 8352569
    [Abstract] [Full Text] [Related]

  • 4. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry].
    Belhoussine R, Morjani H, Manfait M.
    Bull Cancer; 1997 Apr; 84(4):343-9. PubMed ID: 9238156
    [Abstract] [Full Text] [Related]

  • 5. [In vitro characterization of S9788, a new modulator of multidrug resistance].
    Pérez V, Pierré A, Léonce S, Anstett M, Prost JF, Atassi G.
    Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185
    [Abstract] [Full Text] [Related]

  • 6. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.
    Merlin JL, Marchal S, Ramacci C, Dieterlen A, Schultz G, Lucas C, Poullain MG, Berlion M.
    Cytometry; 1995 Aug 01; 20(4):315-23. PubMed ID: 7587719
    [Abstract] [Full Text] [Related]

  • 7. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
    Li R, Wu R, Zhao L, Wu M, Yang L, Zou H.
    ACS Nano; 2010 Mar 23; 4(3):1399-408. PubMed ID: 20148593
    [Abstract] [Full Text] [Related]

  • 8. Confocal scanning microspectrofluorometry reveals specific anthracyline accumulation in cytoplasmic organelles of multidrug-resistant cancer cells.
    Belhoussine R, Morjani H, Millot JM, Sharonov S, Manfait M.
    J Histochem Cytochem; 1998 Dec 23; 46(12):1369-76. PubMed ID: 9815278
    [Abstract] [Full Text] [Related]

  • 9. [Effect of S9788, cyclosporin A and verapamil on intracellular accumulation of doxorubicin, daunorubicin and daunorubicinol in primary rat hepatocyte culture].
    Le Bot MA, Kernaleguen D, Simon I, Berlion M, Riché C.
    Ann Biol Clin (Paris); 1996 Dec 23; 54(1):21-4. PubMed ID: 8731791
    [Abstract] [Full Text] [Related]

  • 10. Effects of verapamil and S9788 on MDR-1 mRNA expression studied by in situ hybridization.
    Joly P, Lallemand A, Oum'Hamed Z, Trentesaux C, Idoine O, Desplaces A.
    Anticancer Res; 1996 Dec 23; 16(6B):3609-14. PubMed ID: 9042229
    [Abstract] [Full Text] [Related]

  • 11. Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil.
    Julia AM, Roché H, Berlion M, Lucas C, Milano G, Robert J, Bizzari JP, Canal P.
    Br J Cancer; 1994 May 23; 69(5):868-74. PubMed ID: 8180016
    [Abstract] [Full Text] [Related]

  • 12. [Effect of the modality of exposure on the action of S9788 on the modulation of multidrug resistance of human tumor cell lines].
    Merlin JL, Marchal S, Ramacci C, Lucas C, Paraire M, Poullain MG.
    Bull Cancer; 1994 Oct 23; 81(10):906-9. PubMed ID: 7734778
    [No Abstract] [Full Text] [Related]

  • 13. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S, Pierré A, Anstett M, Pérez V, Genton A, Bizzari JP, Atassi G.
    Biochem Pharmacol; 1992 Nov 03; 44(9):1707-15. PubMed ID: 1360210
    [Abstract] [Full Text] [Related]

  • 14. [Intracellular accumulation, retention, and distribution of anthracyclines in a multidrug-resistant variant K562r].
    Hu X, Chen WY.
    Zhongguo Yao Li Xue Bao; 1994 May 03; 15(3):275-9. PubMed ID: 7976387
    [Abstract] [Full Text] [Related]

  • 15. [Difference between the effects of S9788, verapamil and quinine on the reversion of multidrug resistance in two human tumor cell lines].
    Bennis S, Robert J.
    Bull Cancer; 1994 Oct 03; 81(10):886-90. PubMed ID: 7734772
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of cyclosporin A on intracellular accumulation and efflux of drug in K562/DOX cells].
    Meng H, Lin X, Lin M.
    Zhonghua Xue Ye Xue Za Zhi; 1997 May 03; 18(5):254-6. PubMed ID: 15622758
    [Abstract] [Full Text] [Related]

  • 17. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
    Tapiero H, Nguyen-Ba G, Lampidis TJ.
    Pathol Biol (Paris); 1994 Apr 03; 42(4):328-37. PubMed ID: 7808786
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.
    Massart C, Gibassier J, Raoul M, Pourquier P, Leclech G, Robert J, Lucas C.
    Anticancer Drugs; 1995 Feb 03; 6(1):135-46. PubMed ID: 7756676
    [Abstract] [Full Text] [Related]

  • 19. Evidence for reversal of multidrug resistance by quinine in LR73 cells without alteration of nuclear pirarubicin uptake and down-regulation of mdr1 gene expression.
    Belhoussine R, Morjani H, Lahlil R, Manfait M.
    Int J Cancer; 1997 Nov 14; 73(4):600-6. PubMed ID: 9389578
    [Abstract] [Full Text] [Related]

  • 20. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
    Nagasawa K, Natazuka T, Chihara K, Kitazawa F, Tsumura A, Takara K, Nomiyama M, Ohnishi N, Yokoyama T.
    Cancer Chemother Pharmacol; 1996 Nov 14; 37(4):297-304. PubMed ID: 8548874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.